Weiss Multi-Strategy Advisers’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-91,562
Closed -$2.64M 348
2023
Q4
$2.64M Buy
+91,562
New +$2.77M 0.06% 337
2023
Q2
Sell
-81,984
Closed -$3.19M 730
2023
Q1
$3.35M Sell
81,984
-4,340
-5% -$187K 0.08% 338
2022
Q4
$4.42M Buy
+86,324
New +$4.14M 0.13% 245
2020
Q2
Sell
-8,669
Closed -$268K 604
2020
Q1
$268K Buy
+8,669
New +$295K 0.01% 377
2016
Q2
Sell
-90,754
Closed -$2.55M 481
2016
Q1
$2.55M Buy
90,754
+63,247
+230% +$1.81M 0.11% 235
2015
Q4
$842K Buy
+27,507
New +$865K 0.06% 260
2014
Q3
Sell
-13,038
Closed -$366K 699
2014
Q2
$367K Sell
13,038
-22,566
-63% -$643K 0.01% 571
2014
Q1
$1.08M Buy
35,604
+14,102
+66% +$420K 0.02% 460
2013
Q4
$625K Buy
21,502
+3,405
+19% +$99.1K 0.01% 557
2013
Q3
$493K Buy
+18,097
New +$492K 0.01% 531

Other funds holding PFE

Weiss Multi-Strategy Advisers's PFE Position: Q1 2024 in Review

Weiss Multi-Strategy Advisers sold out of Pfizer (PFE) in Q1 2024, closing a stake of 91,562 shares — an estimated $2.64M sold.

Weiss Multi-Strategy Advisers first reported a position in PFE in Q3 2013 and held it in 10 quarters. The position peaked at $4.42M in Q4 2022. 2,874 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

  • Weiss Multi-Strategy Advisers reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 91,562 Pfizer shares in Q1 2024, an estimated $2.64M.
  • Weiss Multi-Strategy Advisers first reported a position in Pfizer in Q3 2013 and held it in 10 quarters.
  • Weiss Multi-Strategy Advisers's Pfizer position peaked at $4.42M in Q4 2022.
  • 2,874 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2024.